Crystalvue Medical Corporation (6527.TWO)
TWD 85.3
(-0.7%)
TWD 85.3
(-0.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 154 Million | 51.76 Million | 63.25 Million | 83.54 Million | - |
| Net Income | 119.73 Million | 142.43 Million | 109.16 Million | 62.96 Million | - |
| Depreciation & Amortization | 29.17 Million | 26.15 Million | 40.88 Million | 25.4 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 11.08 Million |
| Change in working capital | 7.12 Million | -93.58 Million | -47.35 Million | -4.5 Million | - |
| Other non-cash items | -656 Thousand | 524 Thousand | 112 Thousand | -547 Thousand | - |
| Investing Cash Flow | -9.12 Million | -4.51 Million | -193.91 Million | -184.97 Million | - |
| Investments in PPE | -8.54 Million | -9.01 Million | -351.95 Million | -103.54 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -1.01 Million | 4.41 Million | - | -85.45 Million | - |
| Sales/Maturities of investments | 173 Thousand | - | 90.82 Million | - | - |
| Other Investing Activities | 260 Thousand | 81 Thousand | -1.94 Million | 4.02 Million | - |
| Financing Cash Flow | -48.09 Million | -64.47 Million | -39.43 Million | -88.8 Million | - |
| Debt repayment | - | - | - | - | - |
| Dividends payments | -56.76 Million | -46.29 Million | -33.4 Million | -61.9 Million | - |
| Common Stock Repurchased | - | -11.97 Million | - | -21.04 Million | - |
| Common Stock Issuance | 15.05 Million | - | - | - | 199.28 Million |
| Other Financing Activities | -6.38 Million | - | - | -21.04 Million | -12.78 Million |
| Accounts receivables | 38.44 Million | - | - | - | - |
| Accounts payables | 450 Thousand | - | - | - | - |
| Inventory | -29.2 Million | -61.17 Million | -37.62 Million | 114 Thousand | - |
| Other working capital | -2.12 Million | - | - | - | - |
| Cash at beginning of period | 176.55 Million | 193.78 Million | 363.87 Million | 554.1 Million | - |
| Cash at end of period | 273.34 Million | 176.55 Million | 193.78 Million | 363.87 Million | - |
| Capital Expenditure | -8.54 Million | -9.01 Million | -351.95 Million | -103.54 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 96.79 Million | -17.22 Million | -170.09 Million | -190.23 Million | - |
| Free Cash Flow | 145.46 Million | 42.75 Million | -288.69 Million | -20 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 35.19 Million | 39.07 Million | 25.96 Million | 119.73 Million | 29.13 Million | 32.78 Million |
| Depreciation & Amortization | 7.94 Million | 8.4 Million | 8.08 Million | 29.17 Million | 7.88 Million | 6.86 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 19.9 Million | - |
| Change in working capital | -17.27 Million | -37.45 Million | 35.91 Million | 7.12 Million | 651 Thousand | 18.47 Million |
| Other non-cash items | -756 Thousand | 107 Thousand | -502 Thousand | -656 Thousand | -46 Thousand | -300 Thousand |
| Investing Cash Flow | -43.95 Million | 2.33 Million | -3.36 Million | -9.12 Million | -1.09 Million | -2.04 Million |
| Investments in PPE | -43.72 Million | -1.9 Million | -5.52 Million | -8.54 Million | -1.03 Million | -823 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -1.01 Million | -1.01 Million | 4000.00 | - |
| Sales/Maturities of investments | - | 3.01 Million | 4000.00 | 173 Thousand | -3000.00 | 172 Thousand |
| Other Investing Activities | -236 Thousand | 1.23 Million | 3.17 Million | 260 Thousand | -60 Thousand | -1.39 Million |
| Financing Cash Flow | 1.09 Million | -1.62 Million | -1.61 Million | -48.09 Million | -43.31 Million | -1.59 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | -56.76 Million | - | - |
| Common Stock Repurchased | - | - | -15.05 Million | - | 15.05 Million | - |
| Common Stock Issuance | 2.73 Million | - | - | 15.05 Million | - | - |
| Other Financing Activities | -1.63 Million | - | - | - | - | - |
| Accounts receivables | -29.49 Million | - | - | - | - | - |
| Accounts payables | -15.1 Million | - | - | - | - | - |
| Inventory | 18.58 Million | -25.48 Million | 12.83 Million | -29.2 Million | -22.88 Million | 4.32 Million |
| Other working capital | 8.74 Million | - | - | - | - | - |
| Cash at beginning of period | 284.07 Million | 273.34 Million | 208.41 Million | 176.55 Million | 195.26 Million | 163.39 Million |
| Cash at end of period | 246.58 Million | 284.07 Million | 273.34 Million | 273.34 Million | 208.41 Million | 195.26 Million |
| Capital Expenditure | -43.72 Million | -1.9 Million | -5.52 Million | -8.54 Million | -1.03 Million | -823 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -37.49 Million | 10.72 Million | 64.93 Million | 96.79 Million | 13.15 Million | 31.87 Million |
| Free Cash Flow | -38.34 Million | 8.1 Million | 64.38 Million | 145.46 Million | 56.52 Million | 34.68 Million |
6233
LANDP
3556
RYAN
4OQ1
KA8